Chardan Capital Maintains Buy on Cognition Therapeutics, Maintains $11 Price Target Analyst ratings measure the expected performance of a stock during a given time period. Analysts and brokerage ...

Rotating the opal against a background helps when you’re determining its type and evaluating its play-of-color and cut. Is it a black opal, white opal ... No matter the color or combination of colors, ...

A sharp decline in its Medicare Star Ratings for 2025 has prompted Humana (NYSE:HUM) to file a lawsuit in a Texas federal court, seeking a reversal of the cut, Bloomberg News reported Saturday.

GIA IT will be performing maintenance on our internal systems from Friday, October 18th (5 PM PT) to Saturday, October 19th 2024 (8 PM PT). During this maintenance window, the My Lab application, ...

Along with those ratings actions, it cut the long-term issuer rating of TD Group US Holdings LLC to A3 from A2. In addition, ...

On Friday, Baird adjusted its outlook on MiNK Therapeutics (NASDAQ:INKT) shares, reducing the price target to $4 from the previous $8 while maintaining an Outperform rating. The firm's analyst ...

(NASDAQ:GNLX), lowering the price target to $30 from $32, while maintaining a Buy rating on the stock. The revision followed Genelux's earnings report for the third quarter of 2024 and a corporate ...

So she just wanted to take a break," Teresa said, before sharing what Gia is working on in the meantime. "Right now and she’s focusing on her influencing career, and she’s doing phenomenal ...